| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Athenex, Inc. | Officer | Common Stock | 5,310 | $7,222 | $1.36 | 03 Aug 2021 | Direct |
| ADAPTIN BIO, INC. | Executive Chairman, Director, 10%+ Owner | Common Stock | 928,571 | 08 Sep 2025 | Direct | ||
| ADAPTIN BIO, INC. | Executive Chairman, Director, 10%+ Owner | Stock Option (right to buy) | 192,231 | 08 Sep 2025 | Direct | ||
| Athenex, Inc. | Officer | Restricted Stock Units | 30,000 | 03 Aug 2021 | Direct | ||
| Athenex, Inc. | Officer | Stock Option (Right to Buy) | 30,000 | 03 Aug 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000121390025086582-pedder-simon-2025-09-08 | ADAPTIN BIO, INC. | 08 Sep 2025 | 1 | $0 | 4 | Executive Chairman, Director, 10%+ Owner | 10 Sep 2025, 16:59 |
| /report/000121390025014970-pedder-simon-2025-02-11 | ADAPTIN BIO, INC. | 11 Feb 2025 | 0 | $0 | 3 | Executive Chairman, Director, 10%+ Owner | 18 Feb 2025, 18:25 |
| /report/000120919121049982-pedder-simon-2021-08-03 | Athenex, Inc. | 03 Aug 2021 | 2 | $0 | 4 | Officer | 05 Aug 2021, 17:07 |